Urolithin A and Blood Pressure: What to Know

If you have found your way here after seeing blood pressure mentioned alongside urolithin A, the honest answer is worth stating up front: there is no established human evidence that urolithin A lowers blood pressure, and it is not a treatment for hypertension. What follows is a careful look at what the science actually supports, why the mitochondria-versus-blood-pressure distinction matters, and the levers that genuinely move the needle.

The short answer on urolithin A and blood pressure

Urolithin A is a gut postbiotic — a compound your microbiome produces when it breaks down ellagitannins found in pomegranate, walnuts, and certain berries. Its studied role is cellular, specifically supporting a process called mitophagy, the housekeeping system that recycles worn-out mitochondria so cells can keep producing energy efficiently. That is a very different biological target from the network of arteries, kidneys, hormones, and nervous-system signals that together determine your blood pressure.

Across the human clinical trials conducted to date, blood pressure has not been a benefit that researchers set out to demonstrate or reported as an outcome. When people ask whether urolithin A can bring down a reading, the accurate response is that the compound has not been shown to do this, and no one should treat it as a substitute for a proven approach. This page stays strictly within what the evidence allows: urolithin A is a supplement that supports mitochondrial health, not a therapy for high blood pressure. If your numbers are elevated, that is a conversation for your doctor, not a supplement label.

What urolithin A is actually studied for

It helps to separate the strongest human findings from the earlier, more speculative work. Organizing the evidence by strength is the fairest way to understand what this ingredient can and cannot claim.

Proven in humans: muscle and mitochondrial signals

The first-in-human study, Andreux and colleagues in Nature Metabolism (2019), established that urolithin A is safe and well tolerated at doses up to 1,000 mg per day and produced a measurable mitochondrial gene-expression signature in older adults. Building on that, Liu and D'Amico and colleagues (JAMA Network Open, 2022) ran a roughly four-month trial in older adults and observed improvements in muscle endurance, measured as the number of muscle contractions performed before fatigue. Singh and colleagues (Cell Reports Medicine, 2022) tested 500 mg and 1,000 mg arms in middle-aged adults over four months and reported benefits for muscle strength and exercise performance. None of these trials measured a blood-pressure benefit — their endpoints were about muscle and cellular energy.

Newer human research: immunity and recovery

More recent work has extended the picture in other directions, though still not toward blood pressure. A 2025 randomized controlled trial in Nature Aging found that a roughly 28-day course supported the mitochondrial health of immune cells in midlife adults, a finding relevant to the low-grade inflammation sometimes called inflammaging. A 2024 randomized trial in the Journal of the International Society of Sports Nutrition looked at eight weeks of supplementation in resistance-trained men and reported effects on endurance and recovery markers, and a 2025 trial in distance runners added to the exercise-performance literature. These are encouraging but modest, and none reframes urolithin A as a cardiovascular medication.

Preclinical only: the areas still being explored

Much of the excitement around urolithin A traces back to preclinical work — studies in animals and cells that suggest possibilities but do not prove human effects. Ryu and colleagues (Nature Medicine, 2016) provided the foundational demonstration of mitophagy, extended lifespan in the worm C. elegans, and improved muscle function in rodents. Later preclinical work has explored joint and cartilage mitochondrial health in osteoarthritis models (D'Amico and colleagues, Aging Cell, 2022), and early research is examining skin, gut, brain, and heart tissue. When you see heart or cardiovascular mentions attached to urolithin A, they almost always live in this preclinical bucket. Preclinical is a reason for scientists to keep investigating; it is not a basis for a health claim in people, and certainly not for managing blood pressure.

Mitochondria versus blood pressure: why they are not the same story

It is easy to blur these two ideas because both involve the word energy and both matter for how you feel day to day. But they operate on different levels. Mitochondria are the microscopic power plants inside your cells; supporting their upkeep is about cellular efficiency and, in the studied contexts, muscle output. Blood pressure is a whole-system property — it reflects how hard your heart pumps, how flexible and open your arteries are, how your kidneys handle sodium and fluid, and how stress hormones and your nervous system tune everything moment to moment.

A supplement can plausibly support the first without touching the second. That is exactly why the trials that showed muscle and mitochondrial benefits did not translate into blood-pressure claims: the mechanism simply does not point there in humans. Anyone marketing urolithin A as a way to control hypertension is reaching well beyond the evidence. The systematic review 'Targeting aging with urolithin A in humans' (Ageing Research Reviews, 2024) is candid that the human evidence base is still emerging, built on short trials with modest sample sizes — an important dose of humility whenever a broad benefit is implied.

The levers that genuinely lower blood pressure

If blood pressure is your real concern, the good news is that some of the most effective tools are well established and within reach. Major clinical evidence and guideline bodies point consistently to a handful of levers.

Diet

The DASH eating pattern — rich in vegetables, fruit, whole grains, legumes, nuts, and low-fat dairy, and lower in saturated fat and added sugar — has repeatedly been shown to reduce blood pressure, sometimes within weeks. Reducing dietary sodium and increasing potassium-rich foods amplifies the effect for many people.

Movement and weight

Regular aerobic activity, along with weight loss when appropriate, is among the most reliable non-drug ways to bring readings down. Even modest, sustained changes accumulate.

Alcohol, sleep, and stress

Limiting alcohol, treating poor sleep and sleep apnea, and building genuine stress-management habits all contribute. None of these is glamorous, but together they are far better validated than any supplement for this purpose.

Prescribed medication when needed

For many people, lifestyle change is enough; for others, medication is the right and responsible tool. Both decisions belong with a clinician who can see your full picture and monitor your numbers over time.

Not a treatment — see your doctor. Urolithin A is not a treatment, cure, or preventive for high blood pressure or any cardiovascular condition. If your blood pressure is elevated, or if you take antihypertensive medication, please work with a qualified healthcare provider before adding any supplement, and never stop or change a prescription on your own.

If you still want to take urolithin A

Plenty of people take urolithin A for the reasons it is actually studied — supporting mitochondrial health, muscle endurance, and recovery as they age — while managing blood pressure through the proven levers above. There is nothing contradictory about that. The clinically studied range is 500 to 1,000 mg per day, and the human safety data at 1,000 mg is reassuring, though as always you should confirm suitability with your own clinician, especially if you have a heart or kidney condition or take prescription medicine. For the wider picture, our urolithin A guide walks through the mechanism and evidence in depth, and if you are comparing products, best urolithin A gummies lays out what to look for. You can also read more on urolithin A benefits and side effects to set realistic expectations.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.